Zacks Small Cap Research on MSN4d
LEXX: IRB Approval Clears Way for GLP-1 Study #5LEXX READ THE FULL LEXX RESEARCH REPORT Lexaria Bioscience Corporation (NASDAQ:LEXX) reported fiscal first quarter 2025 ...
clinicaltrialsarena on MSN3d
60 Degrees Pharmaceuticals obtains IRB approval for chronic babesiosis therapy trialDegrees Pharmaceuticals has received approval from the IRB for a Phase II trial of Arakoda (tafenoquine) for treating chronic babesiosis.
Information related to the IRB submission process. The UB IRB has updated the HRP-503 Template ... Modifications and Continuing Review submissions of currently approved studies will still be accepted ...
IRB Approval letters include the IRB Approval dates and the date in which the Continuing Review or Check-in should be submitted to the IRB. This is 90 days prior to the expiration date for Continuing ...
Investigational Review Board (IRB) approval has been granted for the open-label study to evaluate tafenoquine for treatment of patients with a presumptive diagnosis of chronic babesiosis in ...
US-based pharmaceutical company 60 Degrees Pharmaceuticals has received approval from the investigational review board (IRB) for a Phase II trial of Arakoda (tafenoquine) for treating chronic ...
Degrees Pharmaceuticals (SXTP) announced the approval of an Investigational Review Board, IRB, sanctioned Phase II clinical study. The study ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback